Kao Corp
TSE:4452
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kao Corp
Other Equity
Kao Corp
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Kao Corp
TSE:4452
|
Other Equity
¥150.5B
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shiseido Co Ltd
TSE:4911
|
Other Equity
¥151.7B
|
CAGR 3-Years
27%
|
CAGR 5-Years
77%
|
CAGR 10-Years
25%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Other Equity
¥26.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Kose Corp
TSE:4922
|
Other Equity
¥33.3B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
F
|
Fancl Corp
TSE:4921
|
Other Equity
¥132m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Other Equity
¥13.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
Kao Corp
Glance View
In the bustling landscape of Japanese industry, Kao Corporation stands as a quintessential example of ingenuity and adaptability. Founded in 1887, this venerable company began its journey by producing a humble product—washing powder—yet soon expanded beyond its domestic confines to establish a robust global presence. Driven by a philosophy of enriching lives with innovative solutions, Kao operates primarily in the chemical and consumer goods sectors. These include beauty care products, sanitary and health items, and a range of chemical products, used industrially. The company's deep-rooted commitment to research and development enables it to continually advance in areas such as cosmetics and hygiene, which underpins its vast portfolio of brands like Biore, Jergens, and John Frieda. Kao's relentless dedication to quality and sustainability has propelled it to a formidable position, proving its mettle in an industry where adaptability is key. Enterprising at heart, Kao leverages a sophisticated understanding of consumer needs and market demands to fuel its economic engine. The company's revenue streams are intricately woven from both its B2C sales, powered by the proliferation of its household and beauty products, and B2B engagements through its specialty chemical solutions. This dual approach not only diversifies its income channels but also hedges against market volatility. By synergizing its product lines with an emphasis on eco-friendly innovations, Kao not only captures a loyal customer base but also aligns itself with global sustainability goals. In essence, Kao's fusion of tradition with forward-thinking strategies crafts a compelling narrative of a company that knows how to thrive by aligning its mission with market evolution.
See Also
What is Kao Corp's Other Equity?
Other Equity
150.5B
JPY
Based on the financial report for Dec 31, 2025, Kao Corp's Other Equity amounts to 150.5B JPY.
What is Kao Corp's Other Equity growth rate?
Other Equity CAGR 3Y
58%
Over the last year, the Other Equity growth was 21%. The average annual Other Equity growth rates for Kao Corp have been 58% over the past three years .